 |
Articles: Drug Approvals |
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing–remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies
Clinical Immunology, 05/06/09
Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes
Amylin Pharmaceuticals, 05/06/09
Free full text
FDA Grants Accelerated Approval of Avastin for Brain Cancer (Glioblastoma) That Has Progressed Following Prior Therapy
Genentech, 05/06/09
Free full text
AstraZeneca submits NDA for low dose aspirin/esomeprazole combination product
AstraZeneca, 05/05/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/04/09
Free full text
FDA Grants Orphan Drug Designation to Oncophage for the Treatment of Glioma
Antigenics, 05/01/09
Free full text
FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill
Novartis, 05/01/09
Free full text
Antigenics' Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Brain Cancer
Antigenics, 04/30/09
Free full text
Watson Confirms Filing of Abbreviated New Drug Application for Generic Enablex
Watson Pharmaceuticals, 04/29/09
Free full text
AVI BioPharma Receives Key Patents for Drug Candidate AVI-6002 Targeting Ebola Zaire Virus Protein VP35
AVI BioPharma, 04/29/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 04/28/09
Free full text
Onyx Pharmaceuticals Announces A Teleconference And Webcast To Provide An Update On Nexavar
Onyx Pharmaceuticals, 04/28/09
Free full text
FDA Approves Monthly Injectable Drug for Treating Three Types of Immune-Related Arthritis
FDA Press Releases, 04/27/09
Free full text
Amylin Issues Statement in Response to Carl Icahn
Amylin Pharmaceuticals, 04/27/09
Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 04/27/09
Free full text
U.S. Food and Drug Administration Extends Review Timeline for ONGLYZA (saxagliptin) New Drug Application
Bristol Myers-Squibb Company, 04/24/09
Free full text
Elan and Transition Therapeutics Receive Key Patent for Alzheimers Disease Treatment with ELND005
Elan, 04/24/09
Free full text
FDA Researchers Contribute Insights into Avian Flu Virus
FDA Press Releases, 04/22/09
Free full text
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
Forest Laboratories, 04/21/09
Free full text
Myriad Genetics, Inc. Receives Approval From New York Stock Exchange to Proceed With New Listing
Myriad, 04/16/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
166 Available Pages
|
|
